-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Oxycodone MR + Promethazine IR) in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Oxycodone MR + Promethazine IR) in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Oxycodone MR + Promethazine IR) in Pain Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Orenipro IR in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Orenipro IR in Pulmonary Arterial Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Orenipro IR in Pulmonary Arterial Hypertension Drug Details: Orenipro (oral...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dalfampridine IR in Spinocerebellar Ataxia (SCA)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dalfampridine IR in Spinocerebellar Ataxia (SCA) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dalfampridine IR in Spinocerebellar Ataxia (SCA) Drug Details: Dalfampridine is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pramipexol Dihydrochloride IR in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pramipexol Dihydrochloride IR in Major Depressive Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pramipexol Dihydrochloride IR in Major Depressive Disorder Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Capsulin IR in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Capsulin IR in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Capsulin IR in Type 1 Diabetes (Juvenile Diabetes)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PHVS-416 in Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PHVS-416 in Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PHVS-416 in Hereditary Angioedema (HAE)...
-
Analyst Opinions
NewNew Prescription – Generative AI Meets Healthcare (Vol. 2)
Generative Artificial Intelligence (AI) in Healthcare Report Overview GenAI is generating considerable buzz within the healthcare sector, from news updates to deal negotiations and company filings primarily to drive down costs and optimize administrative workflows, promising better healthcare. From accelerating R&D to easing administrative tasks and creating personalized patient experiences, genAI innovations have now proliferated across all the major healthcare application areas. The ’Generative Artificial Intelligence (AI) in Healthcare’ research report is a compendium of the latest real-world innovations in...
-
Analyst Opinions
NewBeyond Bytes – Data Center Evolution for Peak Performance
Beyond Bytes – Data Center Evolution for Peak Performance Report Overview The data center and hosting services market size was valued at $107 billion in 2023. The data center services market growth will be driven by the emergence of Generative AI (genAI). Furthermore, a surge in digital content and rapid cloud adoption are a few of the other drivers that will propel the data center services market to register a CAGR of more than 12% from 2023-2027. Data Center and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – UI-014 in Endocrine Gland Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - UI-014 in Endocrine Gland Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. UI-014 in Endocrine Gland Disorders Drug Details: UI-014 is under...